S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Secret Bull Market Starts in This Unusual Sector (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
Biden’s $374B Giveaway Into This Sector (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Urgent alert: open this for a huge profit potential (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Secret Bull Market Starts in This Unusual Sector (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
Biden’s $374B Giveaway Into This Sector (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Urgent alert: open this for a huge profit potential (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Secret Bull Market Starts in This Unusual Sector (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
Biden’s $374B Giveaway Into This Sector (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Urgent alert: open this for a huge profit potential (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Secret Bull Market Starts in This Unusual Sector (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
Biden’s $374B Giveaway Into This Sector (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Urgent alert: open this for a huge profit potential (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Free Trial
NASDAQ:GNOM

Global X Genomics & Biotechnology ETF (GNOM) Price, Holdings, & News

→ Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad)
Free GNOM Stock Alerts
$9.68
-0.10 (-1.02%)
(As of 04/19/2024 ET)
Compare
Today's Range
$9.58
▼
$9.82
50-Day Range
$9.78
▼
$12.29
52-Week Range
$8.63
▼
$13.33
Volume
62,364 shs
Average Volume
68,548 shs
Market Capitalization
$88.28 million
Assets Under Management
$89.12 million
Dividend Yield
0.00%
Net Expense Ratio
0.50%
Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestSocial Media
GNOM stock logo

About Global X Genomics & Biotechnology ETF (NASDAQ:GNOM)

Complete Genomics, Inc. is a life sciences company that has developed and commercialized a deoxyribonucleic acid (DNA) sequencing platform. Its complete genomics analysis platform (CGA) Platform, combines its human genome sequencing technology with its advanced informatics and data management software and its end-to-end, outsourced service model to provide its customers with data that is ready to be used for genome-based research. Its genome sequencing center combines a high-throughput sample preparation facility, a collection of its high-throughput sequencing instruments and a large- scale data center. Its customers include some of the global academic and government research centers and biopharmaceutical companies. Effective March 18, 2013, BGI-Shenzhen announced that through its wholly-owned subsidiary, Beta Acquisition Corporation, it has completed the acquisition of the Company.

GNOM Stock Price History

GNOM ETF News Headlines

April 18, 2024 | markets.businessinsider.com
The Analyst Landscape: 4 Takes On 10x Genomics
March 21, 2024 | investorplace.com
3 Stocks That Could Be the Next Big Thing in Gene Editing
April 19, 2024 | DTI (Ad)
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
March 14, 2024 | finance.yahoo.com
Global X Genomics & Biotechnology UCITS ETF (GNOG.L)
March 6, 2024 | investing.com
Global X Genomics & Biotechnology ETF (GNOM)
December 29, 2023 | msn.com
Global X Cannabis ETF declares $0.1656 dividend
May 12, 2023 | investing.com
Global X S&P 500® Catholic Values ETF (CATH)
April 29, 2023 | benzinga.com
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM), Quotes and News Summary
April 19, 2024 | DTI (Ad)
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
April 15, 2023 | thestreet.com
Complete Genomics Stock Falls On Unusually High Volume (GNOM)
See More Headlines
Receive GNOM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Global X Genomics & Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
Global X
Fund Name
Global X Genomics & Biotechnology ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NASDAQ
Current Symbol
NASDAQ:GNOM
Inception Date
4/5/2019
Fund Manager
Chang Kim, James Ong, Nam To, Wayne Xie
Web
www.completegenomics.com
Phone
+1-650-9432800

Fund Focus

Asset Class
Equity
Benchmark
Solactive Genomics Index
Category
Strategy
Focus
Theme
Development Level
Blended Development
Region
Global
Number of Holdings
44

Fund Statistics

Assets Under Management
$89.12 million
Average Daily Volume
$0.00
Discount/Premium
0.01%

Administrator, Advisor and Custodian

Administrator
Global X Management Company LLC
Advisor
Global X Management Company LLC
Custodian
Brown Brothers Harriman & Co.
Distributor
SEI Investments Distribution Co.
Transfer Agent
Brown Brothers Harriman & Co.
Trustee
N/A
Lead Market Maker
Susquehanna

Options

Optionable
N/A
Short Interest
11,000 shs

Miscellaneous

Outstanding Shares
9,120,000
Beta
1.03
Creation Unit
50,000
Creation Fee
$500.00
20 Stocks to Sell Now Cover
20 Stocks to Sell Now

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report
Ad DTI
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
Click here for the full story

Global X Genomics & Biotechnology ETF Expenses

TypeGNOMTheme ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.50%0.57%0.54%0.48%0.51%
Other Expenses0.00%0.72%0.54%0.34%0.58%
Total Expense0.50%0.72%0.70%0.58%0.70%
Fee Waiver0.00%-0.76%-0.55%-0.22%-0.57%
Net Expense0.50%0.59%0.60%0.54%0.58%

Global X Genomics & Biotechnology ETF (GNOM) Holdings & Exposure

Top 10 GNOM Holdings

GNOM Sector Exposure

GNOM Industry Exposure

Full Holdings Details

GNOM ETF - Frequently Asked Questions

How have GNOM shares performed in 2024?

Global X Genomics & Biotechnology ETF's stock was trading at $11.56 at the beginning of the year. Since then, GNOM stock has decreased by 16.3% and is now trading at $9.68.
View the best growth stocks for 2024 here.

What does GNOM invest in?

Global X Genomics & Biotechnology ETF is a equity fund issued by Global X. GNOM focuses on theme investments and follows the Solactive Genomics Index. The fund's investments total to approximately $89.12 million assets under management.

What stocks does Global X Genomics & Biotechnology ETF hold?

GNOM invests in 44 holdings. Some of the stocks in their portfolio include CRISPR Therapeutics (CRSP), Veracyte (VCYT), Qiagen (QGEN), Ultragenyx Pharmaceutical (RARE), BioMarin Pharmaceutical (BMRN), BioNTech (BNTX), Alnylam Pharmaceuticals (ALNY), Natera (NTRA), Agilent Technologies (A) and Rocket Pharmaceuticals (RCKT).

What is the management fee for Global X Genomics & Biotechnology ETF?

Global X Genomics & Biotechnology ETF's management fee is 0.50% and has no other recorded expenses or fee waivers. The net expense ratio for GNOM is 0.50%.

What other stocks do shareholders of Global X Genomics & Biotechnology ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Global X Genomics & Biotechnology ETF investors own include Inovio Pharmaceuticals (INO), Gilead Sciences (GILD), Intel (INTC), Pfizer (PFE), Quest Diagnostics (DGX), Micron Technology (MU), Dynavax Technologies (DVAX), Matinas BioPharma (MTNB).

How do I buy shares of Global X Genomics & Biotechnology ETF?

Shares of GNOM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:GNOM) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets
Biden’s $374B Giveaway Into This Sector
DTI
SHOCKING Crypto Leak…
Crypto 101 Media
Man Who Predicted 2008: “This Will be Worse.”
Altimetry
BUY ALERT: Billionaires piling into this asset class
Reagan Gold Group